Lake Street Maintains Buy on PetMed Express, Lowers Price Target to $7
Benzinga Newsdesk 2 years ago
NewsPrice TargetAnalyst Ratings
Lake Street analyst Ryan Meyers maintains PetMed Express (NASDAQ:PETS) with a Buy and lowers the price target from $9 to $7.
Lake Street analyst Ryan Meyers maintains PetMed Express (NASDAQ:PETS) with a Buy and lowers the price target from $9 to $7.